Given that either genetic deletion of HDAC4 or late treatment with tasquinimod led to inhibition of renal injury and fibrosis, it remains obscure that the antifibrotic effect of HDAC4 inhibition is primarily due to prevention of renal tubular cell injury or inhibition of renal fibrosis. The gene discussed is HDAC4; the disease is renal fibrosis.